Alterations in insulin-signaling and coagulation pathways in platelets during hyperglycemia-hyperinsulinemia in healthy non-diabetic subject.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Thrombosis Research

• Publication date

  2014-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.thromres.2014.06.029PMID 25042561PMCID PMC4148207
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function.

  2013cited by this paper
• Whole-Blood Tissue Factor Procoagulant Activity Is Elevated in Type 1 Diabetes

  2012cited by this paper
• Dual Regulation of Glycogen Synthase Kinase 3 (GSK3)α/β by Protein Kinase C (PKC)α and Akt Promotes Thrombin-mediated Integrin αIIbβ3 Activation and Granule Secretion in Platelets

  2012cited by this paper
• A Novel Small Molecule 1,2,3,4,6-penta-O-galloyl-α-D-glucopyranose Mimics the Antiplatelet Actions of Insulin

  2011cited by this paper
• The septic milieu triggers expression of spliced tissue factor mRNA in human platelets

  2011cited by this paper
• Glycogen synthase kinase‐3 negatively regulates tissue factor expression in monocytes interacting with activated platelets

  2011cited by this paper
• Platelet Function in Patients with Diabetes Mellitus: From a Theoretical to a Practical Perspective

  2011cited by this paper
• Review article: Coagulation and fibrinolysis in diabetes

  2010cited by this paper
• The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes.

  2010influential reference
• Glycogen synthase kinase 3: more than a namesake

  2009influential reference
• Alterations of insulin signaling in type 2 diabetes: a review of the current evidence from humans.

  2009cited by this paper
• Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis*

  2009cited by this paper
• Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function.

  2008cited by this paper
• Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review.

  2008cited by this paper
• GSK3beta is a negative regulator of platelet function and thrombosis.

  2008cited by this paper
• Active tissue factor pathway inhibitor is expressed on the surface of coated platelets.

  2007cited by this paper
• Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose.

  2007cited by this paper
• Critical nodes in signalling pathways: insights into insulin action

  2006influential reference
• Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects

  2006influential reference
• Bridging the GAP between insulin signaling and GLUT4 translocation.

  2006cited by this paper
• Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand.

  2006influential reference
• Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets

  2006cited by this paper
• Proteomics techniques and their application to hematology.

  2004cited by this paper
• IRS-1 Mediates Inhibition of Ca2+ Mobilization by Insulin via the Inhibitory G-protein Gi*

  2004cited by this paper
• Pharmacological inhibitors of glycogen synthase kinase 3.

  2004cited by this paper
• Transcript profiling of human platelets using microarray and serial analysis of gene expression.

  2003cited by this paper
• Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.

  2003cited by this paper
• Coagulation and Fibrinolysis in Diabetes

  2002cited by this paper
• Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.

  2002cited by this paper
• Prevention Conference VI: Diabetes and Cardiovascular Disease: Executive Summary Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association

  2002cited by this paper
• Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle.

  2002cited by this paper
• Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors.

  2002cited by this paper
• Diabetes mellitus: a hypercoagulable state.

  2001cited by this paper
• Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.

  2000cited by this paper
• Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.

  2000cited by this paper
• Molecular Basis of Insulin-stimulated GLUT4 Vesicle Trafficking

  1999cited by this paper
• Synip: a novel insulin-regulated syntaxin 4-binding protein mediating GLUT4 translocation in adipocytes.

  1999cited by this paper
• The COOH-terminal Tyrosine Phosphorylation Sites on IRS-1 Bind SHP-2 and Negatively Regulate Insulin Signaling*

  1998cited by this paper
• Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease.

  1998cited by this paper
• [Insulin receptor].

  1997cited by this paper

• Effects of subcutaneous vs. oral nanoparticle-mediated insulin delivery on hemostasis disorders in type 1 diabetes: A rat model study

  2024cites this paper
• Difference in Prognosis of Colorectal Cancer Patients with or without Diabetes Mellitus

  2024cites this paper
• Platelet–Lymphocyte Ratio, Neutrophil–Lymphocyte Ratio and Their Dynamic Changes with Type 2 Diabetes Mellitus: A Cohort Study in China

  2022cites this paper
• Prognostic Significance of Plasma Insulin Level for Deep Venous Thrombosis in Patients with Severe Traumatic Brain Injury in Critical Care

  2022cites this paper
• Glucose inhibits haemostasis and accelerates diet-induced hyperlipidaemia in zebrafish larvae

  2021cites this paper
• Circular RNA Expression Profiles in Plasma from Patients with Heart Failure Related to Platelet Activity

  2020cites this paper
• Covid-19 and Metabolic Syndrome.

  2020cites this paper
• Chapter 9 Mechanisms Involved in Diabetes-Associated Platelet Hyperactivation

  2018cites this paper
• COSMIC project: consensus on the objectives of the metabolic syndrome in clinic

  2018cites this paper
• The Platelet Transcriptome: Coding RNAs

  2017cites this paper
• A comparative study of three non-nutritive sweeteners effects on insulin andglucose in healthy, non-diabetic adults.

  2017cites this paper
• Diabetes, Thrombosis, and Cardiovascular Risks

  2017cites this paper
• Metabolic syndrome update.

  2016cites this paper
• Nuclear factor-κB regulates expression of platelet phospholipase C-β2 (PLCB2)

  2016cites this paper
• Mechanisms Involved in Diabetes-Associated Platelet Hyperactivation

  2015cites this paper
• The vulnerable blood. Coagulation and clot structure in diabetes mellitus.

  2015cites this paper
• The vulnerable blood

  2014cites this paper